HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST PREVENTS ADRENOCORTICOTROPIN, BUT NOT INTERLEUKIN-6 RESPONSES TO BACTERIAL-ENDOTOXIN IN RATS

被引:47
作者
SCHOTANUS, K [1 ]
TILDERS, FJH [1 ]
BERKENBOSCH, F [1 ]
机构
[1] FREE UNIV AMSTERDAM,FAC MED,NEUROSCI RES INST,DEPT PHARMACOL,VAN DER BOECHORSTR 7,1081 BT AMSTERDAM,NETHERLANDS
关键词
D O I
10.1210/en.133.6.2461
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study was designed to analyze the role of endogenous interleukin-1 (IL-1) in the ACTH, corticosterone (CORT), and IL-6 responses of rats to bacterial endotoxin. Recombinant rat IL-1beta (rIL-1beta) when given ip resulted in dose-dependent increases in plasma ACTH, CORT, and IL-6 concentrations. Plasma ACTH and CORT responses could be induced by low rIL-1beta doses that did not elevate plasma IL-6 levels. The half-maximally effective dose of rIL-1beta was less than 0.6 mug/kg for the ACTH and CORT responses and higher than 2.5 mug/kg for the IL-6 response. Time-course studies indicated that plasma ACTH and CORT concentrations were already elevated 30 min after the injection of rIL-1beta (2.5 mug/kg, ip), with peak values after 1-2 h, followed by a subsequent decline. In contrast, plasma IL-6 concentrations became elevated 2 h after the injection of rIL-10. In another set of experiments, the administration of endotoxin resulted in a dose-dependent elevation of the plasma ACTH, CORT, and IL-6 concentrations. The dose-response characteristics for ACTH, CORT, and IL-6 were different. The half-maximally effective dose for the ACTH and CORT, and IL-6 responses were approximately 2.5 mug/kg and more than 10 mug/kg, respectively. Time courses of plasma ACTH, CORT, and IL-6 responses to endotoxin (2.5 mug/kg, ip) were similar, with peak values measured after 2 h. When given alone, the human IL-1 receptor antagonist (IL-1RA; 1 or 2.5 mg/kg, ip) did not affect resting plasma ACTH and CORT concentrations and reduced plasma IL-6 concentrations in one experiment. At a dose of 1 mg/kg, IL-1RA inhibited ACTH and IL-6 responses to rIL-1beta (2.5 mug/kg, ip) by 75% and 90%, respectively. Administration of IL-1RA (2.5 mg/kg, ip) 30 min after endotoxin (2.5 ug/kg, ip) completely prevented the ACTH response and partially inhibited the CORT response, but did not affect the IL-6 response measured 2.5 h after endotoxin administration. We conclude that 1) IL-1 receptors are involved in the ACTH and IL-6 responses to rat IL-1beta; 2) the ACTH response, but not the IL-6 response, to a low dose dose of endotoxin in rats requires IL-1 receptor activation by endogenous produced IL-1; and 3) circulating IL-6 is not a prime mediator involved in ACTH and CORT responses to low doses of rIL-1beta and endotoxin.
引用
收藏
页码:2461 / 2468
页数:8
相关论文
共 47 条
[11]  
DERIJK R, 1992, AM J PHYSIOL, V263, pE1092
[12]   BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO [J].
DINARELLO, CA ;
THOMPSON, RC .
IMMUNOLOGY TODAY, 1991, 12 (11) :404-410
[13]  
DRIPPS DJ, 1991, J BIOL CHEM, V266, P20311
[14]   THE ROLE OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN THE NEUROCHEMICAL AND NEUROENDOCRINE RESPONSES TO ENDOTOXIN [J].
DUNN, AJ .
BRAIN RESEARCH BULLETIN, 1992, 29 (06) :807-812
[15]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[16]  
GOTO F, 1992, IMMUNOLOGY, V77, P235
[17]  
GRANOWITZ EV, 1991, J BIOL CHEM, V266, P14147
[18]   INTERLEUKIN-1 STIMULATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS [J].
GWOSDOW, AR ;
KUMAR, MSA ;
BODE, HH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (01) :E65-E70
[19]   INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR [J].
HANNUM, CH ;
WILCOX, CJ ;
AREND, WP ;
JOSLIN, FG ;
DRIPPS, DJ ;
HEIMDAL, PL ;
ARMES, LG ;
SOMMER, A ;
EISENBERG, SP ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :336-340
[20]   THE EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN (IL)-1-ALPHA, IL-1-BETA OR IL-6 ON HYPOTHALAMO-PITUITARY-ADRENAL AXIS ACTIVATION [J].
HARBUZ, MS ;
STEPHANOU, A ;
SARLIS, N ;
LIGHTMAN, SL .
JOURNAL OF ENDOCRINOLOGY, 1992, 133 (03) :349-355